Back to Search
Start Over
Myeloma MRD by deep sequencing from circulating tumor DNA does not correlate with results obtained in the bone marrow
- Source :
- Blood Advances, Blood Advances, The American Society of Hematology, 2018, 2 (21), pp.2811-2813. ⟨10.1182/bloodadvances.2018025197⟩
- Publication Year :
- 2018
-
Abstract
- Key Points There is no correlation between ctDNA and bone marrow for MRD by NGS using only immunoglobulin gene rearrangements in myeloma patients.
- Subjects :
- 0301 basic medicine
Neoplasm, Residual
Plasma Cells
[SDV.CAN]Life Sciences [q-bio]/Cancer
Deep sequencing
Circulating Tumor DNA
03 medical and health sciences
0302 clinical medicine
Bone Marrow
hemic and lymphatic diseases
medicine
Biomarkers, Tumor
Neoplasm
Humans
Multiple myeloma
ComputingMilieux_MISCELLANEOUS
Extramural
business.industry
High-Throughput Nucleotide Sequencing
Hematology
Sequence Analysis, DNA
medicine.disease
Stimulus Report
V(D)J Recombination
3. Good health
body regions
030104 developmental biology
medicine.anatomical_structure
Circulating tumor DNA
030220 oncology & carcinogenesis
Cancer research
Bone marrow
Immunoglobulin Gene Rearrangement
business
Multiple Myeloma
Subjects
Details
- ISSN :
- 24739537 and 24739529
- Volume :
- 2
- Issue :
- 21
- Database :
- OpenAIRE
- Journal :
- Blood advances
- Accession number :
- edsair.doi.dedup.....789dca70a86d404768e060733f129915